Showing results (161-170 of 330) with videos related to
Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2013
Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutationsJames Chih-Hsin Yang, Vera Hirsh, Martin Schuler, et al.JTO Clinical and Research Reports|January 22, 2026
Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery DataMadhusmita Behera, Gregory Joseph, Manali Rupji, et al.Oncogene|July 21, 2019
Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancerSana Raoof, Iain J Mulford, Heidie Frisco-Cabanos, et al.BMJ Open|August 14, 2025
Blended palliative and survivorship care intervention (POISE) for patients with metastatic oncogene-driven non-small cell lung cancer: study protocol for a pilot randomised controlled trialHeather A Richard, Roshni Sarathy, Dustin J Rabideau, et al.The Pediatric Infectious Disease Journal|December 6, 2008
Rhinoviruses are a major cause of wheezing and hospitalization in children less than 2 years of ageZofia Piotrowska, Marietta Vázquez, Eugene D Shapiro, et al.Water, Air, and Soil Pollution|January 26, 2018
Effect of Silene vulgaris and Heavy Metal Pollution on Soil Microbial Diversity in Long-Term Contaminated SoilMagdalena Pacwa-Płociniczak, Tomasz Płociniczak, Dan Yu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2018
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small Cell Lung CancerJessica J Lin, Emily Chin, Beow Y Yeap, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancerLecia V Sequist, Benjamin Besse, Thomas J Lynch, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 SkippingRebecca S Heist, Lecia V Sequist, Darrell Borger, et al.Scientific Reports|October 31, 2023
Role of sex in lung cancer risk prediction based on single low-dose chest computed tomographyJudit Simon, Peter Mikhael, Ismail Tahir, et al.Pageof 33